Jay Mohr moderates discussion w/ Nick Leschly, Wharton MBA and CEO of Bluebird bio, Inc. during Spotlight Series: Local Leadership & Innovation held at the offices of bluebird bio in Cambridge.  Sponsored by the Wharton Health Care Management Alumni Association and the Wharton Club of Boston.

Bluebird bio, inc. completed its successful IPO last June, helping to make 2013 a remarkable year for the Boston entrepreneurial community as well as the biotech sector. Nick joined the 22-year-old company as Interim President and was named chief bluebird (a.k.a. Chief Executive Officer and President) in 2010. His leadership has included shaping a distinct company culture, building and leading a team through the complexities of clinical trials for gene therapy, and enabling a transition from being a venture-backed start-up to a publicly-traded company.